Morin (C5297): Mechanisms, Evidence, and Benchmarks for a Natural Flavonoid Antioxidant

Executive Summary: Morin (2-(2,4-dihydroxyphenyl)-3,5,7-trihydroxy-4H-chromen-4-one) is a high-purity flavonoid isolated from Maclura pomifera and characterized for use in biomedical research (APExBIO). It acts as an antioxidant, anti-inflammatory, and enzyme inhibitor, notably targeting adenosine 5′-monophosphate deaminase (AMPD) to restore mitochondrial energy metabolism in cellular models of disease (Yang et al., 2025). Morin exhibits robust solubility in DMSO (≥19.53 mg/mL) and ethanol (≥6.04 mg/mL), but is insoluble in water, requiring careful workflow handling. The compound's mechanism and application are validated by HPLC, MS, NMR, and disease model studies. Morin also serves as a fluorescent probe for aluminum ions, broadening its biochemical utility.

Biological Rationale

Morin is a naturally occurring flavonoid with a defined chemical structure: 2-(2,4-dihydroxyphenyl)-3,5,7-trihydroxy-4H-chromen-4-one (CAS 480-16-0). It is isolated from Maclura pomifera and is well-characterized for high-purity research use (≥96.81% by HPLC, MS, NMR) (APExBIO product page). Flavonoids are polyphenolic compounds with recognized roles in plant defense and human health. Morin's structure enables hydrogen donation and metal chelation, underpinning its antioxidant and fluorescent properties. It has been extensively studied for its ability to modulate cellular pathways relevant to oxidative stress, inflammation, mitochondrial dysfunction, and metabolism (Yang et al., 2025). Accumulating evidence links these pathways to the pathogenesis of diabetes, cancer, and neurodegenerative diseases, positioning Morin as a model compound for bench investigation (Related review; this article provides new data on in vivo mitochondrial impacts).

Mechanism of Action of Morin

Morin exerts its bioactivity by modulating redox homeostasis and enzyme activity. The core mechanism involves direct inhibition of adenosine 5′-monophosphate deaminase (AMPD), a key enzyme in the purine nucleotide cycle (PNC). In podocyte models exposed to high fructose, Morin binding to AMPD2 was confirmed via molecular docking and functional assays, resulting in reduced AMPD activity and improved mitochondrial function (Yang et al., 2025). This inhibition restores ATP content, basal oxygen consumption, and maximal mitochondrial respiration. Additionally, Morin’s polyphenolic structure enables radical scavenging and chelation of metal ions, such as aluminum, which is exploited in fluorescent biochemical assays (APExBIO). Morin’s effects extend to modulation of glycolytic flux, suppression of inflammatory mediators, and protection against cellular injury in metabolic disease models.

Evidence & Benchmarks

• Morin inhibits AMPD activity in fructose-exposed podocytes, leading to improved mitochondrial energy metabolism and reduced glycolysis activation (Yang et al., 2025).
• In vivo, Morin administration (dose and vehicle as reported) in high-fructose-diet-fed rats reduced podocyte foot process effacement and normalized urinary albumin-to-creatinine ratio (UACR) (Yang et al., 2025).
• Morin restored glomerular synaptopodin expression in models of high-fructose-induced injury, indicating improved podocyte structural integrity (Yang et al., 2025).
• The compound shows strong binding affinity for AMPD2 as demonstrated by molecular docking studies and functional knockdown experiments (Yang et al., 2025).
• Morin acts as a fluorescent probe for aluminum detection via chelation, with established protocols for in vitro and cell-based assays (APExBIO).
• Validated solubility: ≥19.53 mg/mL in DMSO, ≥6.04 mg/mL in ethanol; insoluble in water (APExBIO).

This article extends the application benchmarks by integrating new in vivo metabolic data not covered in prior reviews (see prior review for mechanism focus).

Applications, Limits & Misconceptions

Morin is deployed in models of metabolic syndrome, diabetes, neurodegenerative diseases, and as a biochemical probe for metal ions. Its robust mechanism and purity enable use in cell viability, cytotoxicity, and mitochondrial assays (see site guide for workflow Q&A; this article provides mechanistic and in vivo context). However, Morin’s hydrophobicity necessitates use of organic solvents; aqueous delivery is not viable. It is not a therapeutic drug and lacks regulatory approval for clinical use. Batch-to-batch purity must be confirmed for quantitative applications.

Common Pitfalls or Misconceptions

• Morin is not water soluble: Attempting aqueous formulation leads to precipitation and reduced bioavailability.
• Not a clinical therapeutic: Morin is for research use only; efficacy and safety in human disease are unproven.
• Enzyme specificity: While AMPD inhibition is verified, Morin may interact with other cellular targets; off-target effects are possible.
• Stability: Morin solutions are stable short-term at -20°C; long-term storage or repeated freeze-thaw cycles can degrade compound integrity.
• Batch purity: Use only verified high-purity product lots to ensure reproducibility in sensitive biochemical assays.

Workflow Integration & Parameters

Morin (C5297) is supplied as a high-purity powder by APExBIO and should be dissolved in DMSO or ethanol. Prepare stock solutions at room temperature under inert atmosphere if possible. Solubility is ≥19.53 mg/mL in DMSO and ≥6.04 mg/mL in ethanol. For cell culture, dilute stocks in compatible buffers to avoid precipitation; final DMSO concentration should not exceed 0.1–0.5% v/v in assays. Store solid Morin at -20°C and protect from light. Use solutions promptly or aliquot and freeze for short-term use. Analytical confirmation by HPLC or MS is recommended prior to quantitative work. For aluminum ion detection, use established fluorescence protocols with excitation/emission parameters suited to the Morin–Al³⁺ complex (Morin product page).

For further scenario-driven guidance, consult the cell viability and workflow Q&A guide (site guide; this article details mechanistic rationale and in vivo benchmarks not emphasized in the workflow guide).

Conclusion & Outlook

Morin (C5297) is a rigorously validated natural flavonoid antioxidant for research on mitochondrial metabolism, enzyme inhibition, and cellular protection in metabolic, neurodegenerative, and inflammatory models. Its high-purity supply by APExBIO, robust bioactivity, and established biochemical utility make it a preferred tool for bench scientists. Future research should further delineate target selectivity and explore structure–activity relationships for therapeutic optimization. For ordering and complete specifications, refer to the Morin product page.